Cristina Comelli
Chief Tech/Sci/R&D Officer at CM&D Pharma Ltd.
Profile
Cristina Comelli is currently the Director of Research & Development at CM&D Pharma Ltd.
and also holds the position of Director at ExPharma Ltd.
She completed her undergraduate degree at the University of Padua.
Cristina Comelli active positions
Companies | Position | Start |
---|---|---|
CM&D Pharma Ltd.
CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Chief Tech/Sci/R&D Officer | 09/12/2009 |
ExPharma Ltd.
ExPharma Ltd. BiotechnologyHealth Technology ExPharma Ltd. is a virtual healthcare company. It specializes in food supplements, foods for special medical purposes, medical devices, and diagnostics. The company was founded on September 4, 2012 and is headquartered in London, the United Kingdom. | Director/Board Member | 01/10/2013 |
Training of Cristina Comelli
University of Padua | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
CM&D Pharma Ltd.
CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Health Technology |
ExPharma Ltd.
ExPharma Ltd. BiotechnologyHealth Technology ExPharma Ltd. is a virtual healthcare company. It specializes in food supplements, foods for special medical purposes, medical devices, and diagnostics. The company was founded on September 4, 2012 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Cristina Comelli